Author

Amélie Gudin-de-Vallerin

Translational Research Unit, Montpellier Cancer Institute (ICM), Montpellier, France;ORCID 0009-0000-2087-7254Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Abdelhay BoulahtoufiD· 1 shared Alexandre Evrard· 1 shared Alice MatheuxiD· 1 shared Céline GongoraiD· 1 shared Eric Fabbrizio· 1 shared Fanny LeenhardtiD· 1 shared Florence BoissièreiD· 1 shared Julia Toucheboeuf· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdelhay BoulahtoufORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 4, 2026

The Pregnane X Receptor (PXR) contributes to phenotypic plasticity and modulates the sensitivity to targeted therapies in melanoma

Stefan D Nicolescu, Alice Matheux, Marina Grimaldi…·Philippe Pourquier

This study shows that PXR expression in melanoma cells increases sensitivity to BRAFi/MEKi treatment and is linked to a melanocytic phenotype.

DOI 10.64898/2026.11.03.762858

humanbulk RNA-seq

𝕏 PostBluesky